Research Article

Spectrophotometric Determination of Gemifloxacin Mesylate, Moxifloxacin Hydrochloride, and Enrofloxacin in Pharmaceutical Formulations Using Acid Dyes

Table 5

Determination of GMF in its pharmaceutical dosage forms applying the standard addition technique.

ReagentTaken (μg mL−1)Pure drug added (μg mL−1)Factive tabletsFlobiotic tabletGemiQue tablets
Total found (μg mL−1)Recovery %a  ± SDTotal found (μg mL−1)Recovery %  ± SDTotal found (μg mL−1)Recovery % ± SD

BCG2.04.05.9699.30 ± 0.785.9899.60 ± 0.676.02
8.09.9199.10 ± 1.0210.02 9.92
1213.9799.80 ± 1.2413.96 13.99
BCP
2.02.03.99699.90 ± 0.663.96 3.97
6.08.02100.20 ± 0.907.98 7.99
1011.9299.30 ± 0.9512.05 11.95
BPB2.04.05.9799.50 ± 0.575.99 6.01
8.09.9799.70 ± 0.769.96 9.97
1213.8799.10 ± 1.1413.97 13.89
BTB2.04.06.03100.50 ± 0.486.01 6.01
8.09.9099.00 ± 0.729.96 9.96
1213.9399.50 ± 0.9713.96 14.04
MO5.05.09.9799.70 ± 0.329.91 9.99
1014.9499.60 ± 0.5615.06 14.97
2024.9599.80 ± 0.9024.88 24.90

Average of six determinations.